Thakker Parth U, Perry Alan G, Hemal Ashok K, Bercu Caleb H, Petrou Steven P, Pak Raymond W, Broderick Gregory A, Thiel David D, Dora Chandler D, Lyon Timothy D, Igel Todd C, Craven Timothy E, Pathak Ram A
Department of Urology, Atrium Wake Forest Baptist Health, Winston-Salem, NC, USA.
Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
Transl Androl Urol. 2024 Jul 31;13(7):1093-1103. doi: 10.21037/tau-24-90. Epub 2024 Jul 16.
In 2012 the United States Preventative Services Task Force (USPSTF) changed its prostate-specific antigen (PSA) screening recommendation to a category "D". The purpose of this study is to examine racial, ethnic, and socioeconomic differences in risk of presentation with metastatic prostate cancer (mPCa) at time of diagnosis before and after the 2012 USPSTF category "D" recommendation.
This is a population-based cohort study. We identified patients with mPCa at diagnosis within the National Cancer Database from 2004-2017. Logistic regression models were used to examine associations of mPCa with age, race, ethnicity, geographic location, education level, income, and insurance status. Linear regression models assuming underlying binomial distribution were fitted to annual percentage of mPCa at diagnosis for years 2012-2017 to evaluate the post category "D" recommendation era.
From 2004 to 2017, 88,987 patients presented with mPCa. A higher percentage of mPCa was noted post-USPSTF category "D" recommendation, with a disproportionately greater increase observed among Hispanics and non-Hispanic Blacks [Δslope/year: Hispanics (0.0092), non-Hispanic Blacks (0.0073) and non-Hispanic Whites (0.0070)]. Insurance status impacts race/ethnicity differently: uninsured Hispanics were 3.66 times more likely to present with mPCa than insured Hispanics, while uninsured non-Hispanic Blacks were 2.62 times more likely to present with mPCa than insured non-Hispanic Blacks. Household income appears to be associated with differences in mPCa, particularly among non-Hispanic Blacks. Those earning <$30,000 were more likely to present with mPCa compared to higher income brackets.
Since the USPSTF grade "D" recommendation against PSA screening, the percentage of mPCa at diagnosis has increased, with a higher rate of increase among Hispanic and non-Hispanic Blacks compared to non-Hispanic Whites.
2012年,美国预防服务工作组(USPSTF)将其前列腺特异性抗原(PSA)筛查建议改为“D”类。本研究的目的是研究在2012年USPSTF“D”类建议前后,诊断时转移性前列腺癌(mPCa)呈现风险的种族、民族和社会经济差异。
这是一项基于人群的队列研究。我们在国家癌症数据库中确定了2004年至2017年诊断为mPCa的患者。使用逻辑回归模型来研究mPCa与年龄、种族、民族、地理位置、教育水平、收入和保险状况之间的关联。对2012年至2017年诊断时mPCa的年度百分比拟合假设潜在二项分布的线性回归模型,以评估“D”类建议之后的情况。
2004年至2017年,有88987例患者被诊断为mPCa。在美国预防服务工作组“D”类建议之后,mPCa的比例更高,西班牙裔和非西班牙裔黑人中观察到的增加比例不成比例地更大[斜率/年变化:西班牙裔(0.0092)、非西班牙裔黑人(0.0073)和非西班牙裔白人(0.0070)]。保险状况对种族/民族的影响不同:未参保的西班牙裔患mPCa的可能性是参保西班牙裔的3.66倍,而未参保的非西班牙裔黑人患mPCa的可能性是参保非西班牙裔黑人的2.62倍。家庭收入似乎与mPCa的差异有关,特别是在非西班牙裔黑人中。与高收入阶层相比,收入低于30000美元的人患mPCa的可能性更大。
自从美国预防服务工作组对PSA筛查给出“D”级建议以来,诊断时mPCa的比例有所增加,与非西班牙裔白人相比,西班牙裔和非西班牙裔黑人的增加率更高。